Security key
834203309
SOLENO THERAPEUTICS INC - COMMON STOCK (SLNO)
CUSIP: 834203309
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 51,293,400
- Total 13F shares
- 20,301,195
- Share change
- +14,911,765
- Total reported value
- $598,794,549
- Price per share
- $29.51
- Number of holders
- 54
- Value change
- +$451,363,927
- Number of buys
- 41
- Number of sells
- 12
Report period
Q3 2023
Institutions
54
Top holders
10
SLNO full security history
Newer quarter: Q4 2023
Previous quarter: Q2 2023
SOLENO THERAPEUTICS INC SEC filings
SOLENO THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 834203309
Recent filing periods:
Top shareholders of SLNO - SOLENO THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
3/4/5
13F
|
10%+ Owner · Company |
4.3%
from 13F
|
3,324,542
mixed-class rows
|
$112,175,587 | — | 26 Sep 2023 | |
| Carlyle Group Inc. |
3/4/5
13F
|
10%+ Owner · Company |
2.3%
from 13F
|
2,293,562
mixed-class rows
|
$55,874,902 | — | 28 Sep 2023 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
1.3%
|
649,841
|
$2,787,818 | — | 30 Jun 2023 | |
| AIGH Capital Management LLC |
13F
|
Company |
0.71%
|
364,306
|
$1,562,873 | — | 30 Jun 2023 | |
| J. Goldman & Co LP |
13F
|
Company |
0.24%
|
120,799
|
$518,228 | — | 30 Jun 2023 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.18%
|
90,858
|
$389,781 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.13%
|
66,054
|
$283,000 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
54,648
|
$234,439 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.1%
|
49,939
|
$214,238 | — | 30 Jun 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.05%
|
24,966
|
$107,104 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
15,448
|
$66,272 | — | 30 Jun 2023 | |
| Bollard Group LLC |
13F
|
Company |
0%
|
2,288
|
$10,000 | — | 30 Jun 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
2,093
|
$8,979 | — | 30 Jun 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
871
|
$3,737 | — | 30 Jun 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
731
|
$3,136 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
342
|
$1,467 | — | 30 Jun 2023 | |
| Balefire, LLC |
13F
|
Company |
0%
|
168
|
$721 | — | 30 Jun 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
40
|
$172 | — | 30 Jun 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
37
|
$159 | — | 30 Jun 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
15
|
$64 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
6
|
$26 | — | 30 Jun 2023 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
1
|
$4 | — | 30 Jun 2023 | |
| Abingworth LLP |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
25,774,464
mixed-class rows
|
$657,560,041 | — | 21 Dec 2018 | |
| Jack W. Schuler |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
36,595
|
$1,335,180 | — | 09 Dec 2022 | |
| Birchview Capital, LP |
13F
|
Company |
—
class O/S missing
|
245,127
|
$1,051,593 | — | 30 Jun 2023 | |
| Gwen A. Melincoff |
3/4/5
|
Director |
—
class O/S missing
|
10,000
|
— | — | 25 May 2023 |
Institutional Holders of SOLENO THERAPEUTICS INC - COMMON STOCK (SLNO) as of Q3 2023
As of 30 Sep 2023,
SOLENO THERAPEUTICS INC - COMMON STOCK (SLNO) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,301,195 shares.
The largest 10 holders included
Vivo Capital, LLC, PERCEPTIVE ADVISORS LLC, Carlyle Group Inc., JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., RA CAPITAL MANAGEMENT, L.P., Fairmount Funds Management LLC, COMMODORE CAPITAL LP, Ikarian Capital, LLC, and Frazier Life Sciences Management, L.P..
This page lists
54
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
22
Q3 2023 holders
54
Holder diff
32
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.